← Back to screener

BOSTON SCIENTIFIC CORP BSX

Rank #1164 · NYSE · $62.4B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
52.8
P/E
39.2
P/B
2.87
ROE
7.3%
Op. Margin
16.5%
Debt Ratio
81%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★☆☆
Average

P/E 39.2x, P/B 2.87x. Ranks in the top 48% of the universe.

Profitability ★★★☆☆
Good

ROE 7.3%. Ranks in the top 40% of the universe.

Safety ★★★☆☆
Good

Debt ratio 81%. Ranks in the top 33% of the universe.

Growth ★★★★☆
Good

Revenue growth of 12.3% year over year. Ranks in the top 30% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$-0.9B$-1.0B$11.3B–96
2012–$-0.7B$-1.1B$11.4B–88
2013–$0.9B$0.4B$6.9B–150
2014$7.0B$-3.9B$-4.1B$6.5B-55.6153
2015$7.1B$0.1B$-0.1B$6.5B1.7164
2016$7.5B$-0.3B$-0.1B$6.3B-4.0187
2017–$-0.3B$-0.2B$6.7B–169
2018$8.4B$0.4B$0.3B$7.0B5.3172
2019$9.0B$1.3B$0.1B$8.7B14.2141
2020$9.8B$1.5B$1.7B$13.9B15.3120
2021$10.7B$1.5B$4.7B$13.9B14.1122
2022$9.9B$-0.1B$-0.1B$15.3B-0.8110
2023$11.9B$1.2B$1.0B$16.6B10.195
2024$12.7B$1.6B$0.7B$17.6B13.0100
2025$14.2B$2.3B$1.6B$21.8B16.581

← See the full screener